The federal government has laid out, in unusual operational detail, what state, tribal, local, and territorial health departments are expected to do when someone arrives in their jurisdiction from the Democratic Republic of the Congo, Uganda, or South Sudan. The guidance assigns health departments an initial exposure assessment, a health education requirement, symptom monitoring across 21 days, and a coordination role when a traveler develops symptoms.
The intensity of that monitoring now depends almost entirely on which country a traveler came from. For anyone who was in, or transited through, an airport in DRC, the current recommendation is twice-daily in-person monitoring by the health department, daily self-monitoring with temperature measurement, staying home and avoiding others, and limiting travel to essential purposes by noncommercial means. Travelers from Uganda or South Sudan face a far lighter regime.
That divergence matters because the outbreak driving it has continued to grow. DRC published a situation update reporting 4,381 confirmed cases and 2,011 related deaths as of August 9, according to the European Center for Disease Prevention and Control, an increase of 172 confirmed cases and 95 deaths from the previous report two days earlier. A total of 704 patients were hospitalized in isolation.
The Two Tracks Health Departments Now Apply
The CDC interim guidance was first published in late May and last updated in early August. It now sorts asymptomatic travelers without high-risk exposures into two groups, and the assigned response differs sharply between them.
Travelers who were in or transited through an airport in DRC receive a risk assessment and health education at their initial encounter, then twice-daily in-person monitoring by the health department for 21 days. They are advised to self-monitor by taking daily temperature measurements, to stay home and avoid contact with others, to delay non-urgent medical or dental care, and to limit travel to essential purposes, such as urgent health care, undertaken by private vehicle or private chartered flight and coordinated by health authorities at both ends.
Travelers who were in or transited through an airport in South Sudan or Uganda receive the initial encounter and are advised to watch their health for 21 days and take their temperature if symptoms develop. Health departments may add an optional check-in. No movement restrictions apply, though the CDC suggests reconsidering international and cruise ship travel due to uncertainty about restrictions and access to health care abroad.
CDC lists DRC in its entirety as an area of concern. Uganda no longer has one, because more than 21 days have passed since its last patient was discharged. South Sudan is included in the guidance without a specific area of concern identified because it borders DRC with high travel volume across a porous shared border.
Health departments are told to attempt the initial encounter as soon as feasible, ideally within 24 hours of receiving CDC's notification, and CDC supplies traveler contact information daily through its data platform. No interventions are recommended for anyone who departed an affected country more than 21 days earlier.
The Coordination Role That Defines the Protocol
The most consequential piece of the guidance is what happens when a monitored traveler develops symptoms. CDC directs health departments to reassess the person's travel and exposure history in light of their clinical presentation, in consultation with CDC subject matter experts, rather than treating travel history alone as sufficient grounds to test. The guidance states plainly that travel by itself is not an epidemiologic risk factor.
The stated purpose is twofold. It gives officials advance warning so a symptomatic traveler does not walk into an emergency department unannounced, allowing infection control precautions to be arranged for transport and arrival. It also prevents unnecessary testing and, importantly, prevents delayed recognition of more common and equally dangerous conditions.
That second point is the one clinicians emphasize. CDC's guidance explicitly warns that managing a symptomatic traveler with no known epidemiologic risk factors as a suspected case can delay diagnosis and treatment of malaria or typhoid while Ebola is ruled out. Malaria kills quickly and is far more likely in a returning traveler from the region.
CDC's Viral Special Pathogens Branch is available 24/7 for clinical consultation through the agency's emergency operations center.
Where This Sits Against Earlier U.S. Measures
MedicalDaily has reported throughout this outbreak on the entry restrictions and airport screening that preceded this guidance, including the renewal of Ebola travel restrictions as case counts climbed. Under current measures, travelers who have been in DRC within 21 days of their flight, including U.S. citizens, are not permitted to board commercial flights bound for the United States, and arriving passengers from or transiting affected countries are redirected to designated airports for public health entry screening.
Airport screening and post-arrival monitoring do different jobs. Screening at a port of entry identifies travelers who are symptomatic on arrival. It cannot identify someone infected but not yet showing symptoms, and the incubation period for Ebola runs from two to 21 days. The health department protocol is the layer that covers that gap.
What is genuinely new here is the operational detail, not the concept. Health departments now have defined tracks, a sample screening tool, a daily electronic feed of traveler contact information, and an expectation that initial contact occurs quickly. The guidance is explicitly interim and subject to revision, and CDC notes that jurisdictions may adopt measures more protective than the federal recommendation.
The Risk Picture for U.S. Households
CDC's outbreak situation summary states that no cases of Ebola disease have been confirmed in the United States from this outbreak and that overall risk to the American public and travelers remains low, while describing the outbreak as spreading substantially faster than previous Ebola outbreaks and now the second largest on record. Bundibugyo virus spreads through direct contact with blood or body fluids of a symptomatic person. It is not airborne.
People at meaningful risk of exposure are those who have recently been in the affected region, particularly humanitarian workers, journalists, missionaries, health personnel, and individuals in direct contact with a confirmed case. Two U.S. citizens have tested positive during this outbreak while in the DRC and were medically evacuated to Germany, and a separate imported case was reported in France.
Anyone who has been in DRC, Uganda, or South Sudan in the past 21 days and develops fever, severe headache, muscle pain, weakness, vomiting, diarrhea, or unexplained bleeding should call their health department or clinician before going anywhere in person, and should mention their travel history. Walking into an emergency department without advance notice is precisely what the guidance is designed to prevent. CDC has posted information for travelers returning from affected areas that health departments can use in education.
Organizations deploying personnel to the region should confirm medical evacuation coverage and symptom reporting protocols before departure. CDC states that no vaccines or specific treatments have been approved to prevent or treat Bundibugyo virus disease, and the licensed Ebola vaccines target the Zaire species rather than this one. Early supportive care improves the chance of survival.
How the Outbreak Reached This Point
DRC and Uganda declared the Bundibugyo virus disease outbreak in mid-May, and the World Health Organization determined days later that it constituted a public health emergency of international concern. The United States restricted entry for travelers recently in the affected region and, soon afterward, began redirecting flights for enhanced screening.
Uganda declared its portion of the outbreak over at the end of July, twelve days after discharging its last patient, with 20 confirmed cases and two deaths in total. DRC's epidemic has continued to accelerate, expanding from a single health zone in Ituri Province to 53 affected health zones across five provinces. WHO's weekly situation report reported a cumulative total of 4,381 confirmed cases and 2,011 confirmed deaths as of August 9, with several hundred additional cases and deaths recorded in the preceding week alone.
Case and death figures reported by DRC remain under continuous review and harmonization, so totals may be revised. MedicalDaily will report on any revision to the interim guidance and on changes to U.S. entry measures.
Key Questions Answered
What does the guidance require health departments to do? Conduct an initial exposure assessment, provide health education, carry out symptom monitoring at a level matched to the country of travel, and coordinate the response if a traveler develops symptoms during the 21-day window.
Which countries are covered? The Democratic Republic of the Congo, Uganda, and South Sudan. DRC is listed in its entirety as an area of concern. Uganda no longer has one, and South Sudan is included because of its shared border and travel volume with the DRC.
Are travelers quarantined? Travelers from DRC are advised to stay home, avoid others, delay nonurgent care, and limit travel to essential purposes by noncommercial means. Travelers from Uganda or South Sudan face no movement restrictions.
What happens after 21 days? No interventions are recommended for people who departed an affected country more than 21 days previously.
Has anyone in the United States been infected? CDC says no cases have been confirmed in the United States from this outbreak. Two U.S. citizens infected while in the DRC were medically evacuated to Germany.
What should a returning traveler do if they feel ill? Call the health department or a clinician before going in person, and state the travel history. CDC guidance specifically aims to prevent symptomatic travelers arriving at facilities without advance notice.
Is there a vaccine? CDC says no vaccine or specific treatment has been approved to prevent or treat Bundibugyo virus disease. The licensed Ebola vaccines target the Zaire species rather than this one.
